# Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation

> **NCT01331720** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 279 (actual)

## Conditions studied

- STERILITY

## Interventions

- **DRUG:** hMG-HP

## Key facts

- **NCT ID:** NCT01331720
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-03
- **Final completion:** 2010-07
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2011-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331720, "Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01331720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*